SMTL ID : 6hay.2 (1 other biounit)

Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:ElonginB

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.24 Å
Oligo State
hetero-1-1-1-1-mer
Ligands
1 x FX8: (2~{S},4~{R})-~{N}-[[2-[2-[2-[2-[4-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]ethoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)
11 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
1 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Farnaby, W. et al., BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat.Chem.Biol. (2019)
Release Date
2019-06-12
Peptides
Probable global transcription activator SNF2L2: A
von Hippel-Lindau disease tumor suppressor: B
Elongin-C: C
Elongin-B: D
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
E
B
F
C
G
D
H

Probable global transcription activator SNF2L2

von Hippel-Lindau disease tumor suppressor

Elongin-C

Elongin-B

Related Entries With Identical Sequence

1lqb.1 | 1lqb.2 | 2c9w.1 | 2izv.1 | 3dcg.1 | 3dcg.2 | 3zng.1 | 3zng.2 | 3zrc.1 | 3zrc.2 | 3zrc.3 | 3zrc.4 | 3zrf.1 | 3zrf.2 | 3zrf.3 | 3zrf.4 | 3ztc.1 | 3ztc.2 | 3ztc.3 | 3ztc.4 | 3ztd.1 | 3ztd.2 | 3ztd.3 | 3ztd.4 | 3zun.1 | 3zun.2 | 3zun.3 | 3zun.4 | 4ajy.1 | 4awj.1  more...